Merck Sharp News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New test detects more cases of cervical cancer

Researchers have developed a simpler and more effective screening method for cervical cancer than the method used today. A comprehensive study shows that the test detects significantly more cancers and precancerous stages.

Joakim dillnerMartin widschwendterKarolinska institutetKarin sundstrDepartment of womenDepartment of clinical scienceChildren healthUniversity of innsbruckInfectious disease epidemiologyClinical scienceSola diagnostics gmbhMerck sharp

Hearing loss in Australian First Nations children at 6-monthly assessments from age 12 to 36 months: Secondary outcomes from randomised controlled trials of novel pneumococcal conjugate vaccine schedules

Amanda Leach and colleagues compare two pneumococcal conjugate vaccines to examine the impact on hearing loss

United statesNorthern territoryGovernment hearing health programCentre of research excellenceResearch council clinical trial centreWa aboriginal health ethics committeeWorld health organizationHearing for learning initiativeVaccines for otitis in children entering schoolEuropean respiratory societyMenzies school of health researchWa department of healthNational healthResearch councilAustralian aboriginal health ethics committeeFirst nations

Updated Data from the Phase 1/2 Study of Olomorasib in KRAS G12C-Mutant Advanced Solid Tumors Presented at the 2024 ASCO® Annual Meeting

/PRNewswire/ Eli Lilly and Company (NYSE: LLY) today announced updated data from the Phase 1/2 clinical trial evaluating olomorasib as a monotherapy in.

United statesJoe fletcherDavid hymanPrnewswire eli lillyEli lillyTimothy burnsExchange commissionAmerican society of clinical oncologyMerck sharp dohmeLilly united statesMerck co incCancer researchClinical oncologyAssociate professorPittsburgh medical center hillman cancerMerck sharp

EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024

EVOKE-01 Study Results in Metastatic NSCLC to Be Presented at an Oral Session at ASCO 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Foster cityUnited statesUnited arab emiratesLuis pazMerdad parseyEuropean unionHead of the medical oncology serviceGilead sciencesAmerican society of clinical oncologyGilead sciences incMerck co incMerck sharp dohmeExchange commissionClinical oncologyLuis paz aresMedical oncology service

Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum

Medicenna To Present Evidence of Durable Single Agent Activity and Potent Immune Effector Response with MDNA11 in the Dose Escalation Portion of Phase 1/2 ABILITY-1 Study at the 10th Annual Oncology Innovation Forum
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesChristina cameronSuperkine immunotherapiesPembrolizumab keytrudaMerck sharp dohmeSafety review committeeMerck co incOncology innovation forumMedicenna therapeutics corpDurable single agent activityPotent immune effector responseDose escalation portionAnnual oncology innovationAnnual oncology innovation forumFahar merchantOrphan drug